IP Library › Assignment 069613/0184
Patent Assignment
Reel/Frame 069613/0184

Assignment of Assignor's Interest

Recorded: 2024-12-17 Pages: 5
Assignor
NABRIVA THERAPEUTICS GMBH
Executed: 2024-11-13
Assignee
ARIVA MED GMBH
LEBERSTRASSE 20, 1110 VIENNA, AUSTRIA
Covered Properties (5)
Siderophore Cephalosporin Conjugates and Uses Thereof
Application: 17/640,506 →
Publication: US 2022/0332728
Pleuromutilin in Derivatives for Treating Viral Infections
Application: 17/919,204 →
Publication: US 2023/0174509
Novel 12-Epi-Mutilin Compounds and Uses Thereof
Application: 18/286,958 →
Publication: US 2024/0208989
Organic Compounds
Patent: 7,816,389 →
Application: 11/814,673 →
Publication: US 2008/0287442
12-Epi Pleuromutilins
Patent: 9,701,628 →
Application: 15/111,390 →
Publication: US 2016/0332963
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 15, 2007
From: THIRRING, KLAUS; ASCHER, GERD; PAUKNER, SUSANNE; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0910 →
Change of Name Sep 24, 2014
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 033813/0230 →
Security Interest Sep 26, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033833/0311 →
Release of Security Interest Nov 13, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037040/0320 →
Assignment of Assignor's Interest Mar 28, 2017
From: THIRRING, KLAUS; HEILMAYER, WERNER; RIEDL, ROSEMARIE; KOLLMANN, HERMANN
To: NABRIVA THERAPEUTICS AG
Reel/Frame 041769/0725 →
Intellectual Property Security Agreement Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Assignment of Assignor's Interest Mar 8, 2022
From: RIEDL, ROSEMARIE; PAUKNER, SUSANNE; WICHA, WOLFGANG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 059197/0045 →
Assignment of Assignor's Interest Jul 1, 2022
From: WEISER, JOSEF; KOLLMANN, HERMANN
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 060425/0233 →
Assignment of Assignor's Interest Jan 5, 2023
From: PAUKNER, SUSANNE; RIEDL, ROSEMARIE; WICHA, WOLFGANG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 062280/0986 →
Release of Security Interest Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest. Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Assignment of Assignor's Interest Jul 23, 2024
From: THIRRING, KLAUS
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 068052/0956 →
Assignment of Assignor's Interest Jul 23, 2024
From: RIEDL, ROSEMARIE; PAUKNER, SUSANNE; WICHA, WOLFGANG; STRICKMANN, DIRK
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 068053/0143 →
Assignment of Assignor's Interest Aug 21, 2024
From: RIEDL, ROSEMARIE; PAUKNER, SUSANNE; WICHA, WOLFGANG; WIESER, JOSEF
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 068357/0983 →
Assignment of Assignor's Interest Oct 31, 2024
From: KLAUS, THIRRING, DR.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 069093/0571 →
Assignment of Assignor's Interest Dec 13, 2024
From: RIEDL, ROSEMARIE; PAUKNER, SUSANNE; WICHA, WOLFGANG; WIESER, JOSEF
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 070067/0945 →
Change of Name Dec 17, 2024
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 069727/0366 →